Sofiva Genomics Co.,Ltd. (TPEX:6615)

Sofiva Genomics Revenue

Sofiva Genomics had revenue of 93.03M TWD in the quarter ending March 31, 2026, a decrease of -3.01%. This brings the company's revenue in the last twelve months to 382.82M, down -10.60% year-over-year. In the year 2025, Sofiva Genomics had annual revenue of 385.71M, down -14.91%.

• Revenue (ttm): 382.82M
• Revenue Growth: -10.60%
• P/S Ratio: 1.86
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 712.58M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	385.71M	-67.61M	-14.91%
Dec 31, 2024	453.31M	-13.49M	-2.89%
Dec 31, 2023	466.80M	-28.98M	-5.84%
Dec 31, 2022	495.78M	-12.64M	-2.49%
Dec 31, 2021	508.42M	19.55M	4.00%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 2, 2026

Data Sources Report a data error